CREON 24000- pancrelipase capsule, delayed release pellets
CREON 3000- pancrelipase capsule, delayed release pellets
CREON 600 ABD - İngilizce - NLM (National Library of Medicine)

creon 24000- pancrelipase capsule, delayed release pellets creon 3000- pancrelipase capsule, delayed release pellets creon 600

abbott laboratories gmbh - pancrelipase lipase (unii: 8myc33932o) (pancrelipase lipase - unii:8myc33932o), pancrelipase protease (unii: 3560d81v50) (pancrelipase protease - unii:3560d81v50), pancrelipase amylase (unii: yoj58o116e) (pancrelipase amylase - unii:yoj58o116e) - pancrelipase, 3000 delayed-release capsules (bulk) pancrelipase, 6000 delayed-release capsules (bulk) pancrelipase, 12000 delayed-release capsules (bulk) pancrelipase, 24000 delayed-release capsules (bulk) pancrelipase, 36000 delayed-release capsules (bulk)

LIPANTIL SUPRA 145 Milligram Coated Tablets İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil supra 145 milligram coated tablets

abbott healthcare products ltd - fenofibrate - coated tablets - 145 milligram

LIPANTIL MICRO 67 Milligram Capsules Hard İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil micro 67 milligram capsules hard

bgp products ltd - fenofibrate - capsules hard - 67 milligram - fibrates - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Lipantil Micro 200mg capsules, hard. İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil micro 200mg capsules, hard.

bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

LIPANTIL SUPRA 145 Milligram Film Coated Tablet İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil supra 145 milligram film coated tablet

bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following:  treatment of severe hypertriglyceridaemia with or without low hdl cholesterol.  mixed hyperlipidaemia when a statin is contraindicated or not tolerated.  mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

Lipantil Micro 67 mg hard capsules. İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil micro 67 mg hard capsules.

mylan ire healthcare limited - fenofibrate - capsule, hard - 67 milligram(s) - fibrates; fenofibrate

Lipantil Supra 145mg film-coated tablets İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil supra 145mg film-coated tablets

mylan ire healthcare limited - fenofibrate - film-coated tablet - 145 milligram(s) - fibrates; fenofibrate

Lipantil Supra 215 mg, film-coated tablet İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lipantil supra 215 mg, film-coated tablet

mylan ire healthcare limited - fenofibrate - film-coated tablet - 215 milligram(s) - fibrates; fenofibrate